WASHINGTON, May 30, 2018 /PRNewswire/ -- Avant Diagnostics, Inc. ("Avant") (OTC: AVDX), an oncology-focused healthcare data-generating solutions company commercializing the proprietary Theralink® phospho-protein biomarker platform across multiple cancers, today announced that it has...
from PR Newswire: //https://ift.tt/2slrMfp
No comments:
Post a Comment